©The Author(s) 2021.
World J Gastrointest Oncol. Sep 15, 2021; 13(9): 1086-1098
Published online Sep 15, 2021. doi: 10.4251/wjgo.v13.i9.1086
Published online Sep 15, 2021. doi: 10.4251/wjgo.v13.i9.1086
Table 1 Causes of malignant gastric outlet obstruction
| Site | Pathology |
| Stomach | Distal gastric cancer |
| Gastric lymphoma (e.g., MALT lymphoma) | |
| Leiomyosarcoma | |
| Gastrointestinal stromal tumor | |
| Gastric neuroendocrine neoplasms | |
| Pancreas | Pancreatic adenocarcinoma |
| Cystic neoplasm of the pancreas | |
| Duodenum | Duodenal cancer |
| Leiomyosarcoma | |
| Neoplasm of the ampulla | |
| Gastrointestinal stromal tumor | |
| Metastasis | |
| Gallbladder and bile duct | Gallbladder and bile duct cancer |
| Other | Retroperitoneal lymphadenopathy (e.g., metastatic tumor, lymphoma) |
| Retroperitoneal sarcoma |
- Citation: Cominardi A, Tamanini G, Brighi N, Fusaroli P, Lisotti A. Conservative management of malignant gastric outlet obstruction syndrome-evidence based evaluation of endoscopic ultrasound-guided gastroentero-anastomosis. World J Gastrointest Oncol 2021; 13(9): 1086-1098
- URL: https://www.wjgnet.com/1948-5204/full/v13/i9/1086.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i9.1086